Premium Information is available for this item - Upgrade for $1 a day
6505-01-234-2219
Usp Potassium Chloride For Injection Concentrate
6505012342219 012342219 NDC00467-0067-15 967-30
INC: 48876 Potassium Chloride For Injection Concentrate
January 2023
4
Marketplace 6505-01-234-2219
Request a Quotation from participating marketplace vendors
Related Documents 6505-01-234-2219 1+ Documents (More...)
2023 NATO Update Count 4 NATO Data Quality NSN 6505-01-234-2219 (Generic Image) 1/1 1.
RQST NE Updated Every Day 6505-01-234-2219 RQST Updated Every Day 6505-01-234-2219 RQST NE Related Documents
Restrictions 6505-01-234-2219
6505-01-234-2219 is a Usp Potassium Chloride For Injection Concentrate that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. The precious metals content of this item is unknown.
Import and Export 6505-01-234-2219
- Schedule B
- Subscribe to View Schedule B
- HTS Code
- Subscribe to View HTS Code
End Users 6505-01-234-2219
- MOE Rule:
- V542
- Effective Date:
- 1 Apr 1991
Approved Sources 6505-01-234-2219
- Part Number
- Manufacturer
- Status
- NDC00467-0067-15
- Manufacturer
- 60567 - Lyphomed Inc Div Of Fujisawa Usa Inc (Obsolete)
- Primary Buy
- Primary Buy
- 967-30
- 60567 - Lyphomed Inc Div Of Fujisawa Usa Inc (Obsolete)
- Primary Buy
- Primary Buy
Datasheet 6505-01-234-2219
- Characteristic
- Specifications
- FIIG
- Specifications
- A45100
- Active Medicament Medicinal Strength [AKJA]
- 60.000 Milliequivalents Potassium Chloride Active Ingredient
- Pharmaceutical Vehicle Type [AKJQ]
- Aqueous
- Administration [CSGS]
- Intravenous
- Primary Container Type [CQCT]
- Vial
- Primary Container Content Quantity [CRLK]
- 30.000 Milliliters
- Total Primary Container Quantity [CSCW]
- 25
- Features Provided [CBBL]
- Sterile
- Special Features [FEAT]
- Multiple Dose Vial; Ph Adjusted With Hydrochloric Acid If Necessary
- Therapeutic Equivalent [THPE]
- Any A Rated Drug
Management Data 6505-01-234-2219
- Effective Date
- Organization
- Unit of Issue
- Unit Price
- Qty Unit Pack
- Unit of Issue
- Jun 1986
- Veterans Administration (VA)
- BX
- Subscribe
- BX
- MOE
- USC
- Code
- Statement
- Order of Use
- Jump To Code
- Qty Per Assy
- UOM
- Technical Document
- Quantative Expression
- Code
- Veterans Administration (VA)
- V
- K
- U/I Contains 25 Ea
- 00000000025EA
- K
Similar Supply Items to 6505-01-234-2219
Freight Information 6505-01-234-2219
6505-01-234-2219 has freight characteristics.. 6505-01-234-2219 has a variance between NMFC and UFC when transported by rail and the description should be consulted.